News

Alfredo Sadun, MD, PhD, is the chief of Ophthalmology at the Doheny Eye Institute of UCLA. At this year's AAO meeting held in Chicago, Illinois, he stopped by the Eye Care Network booth to share insights from the symposium "Professional Longevity 2.0: Assessing the Ophthalmologist," which he presented during.

In this final episode, DMEI’s residents share their future plans for expanding the device capabilities and offer practical advice to other up-and-coming creators in eye care technology.

Investigators from Bergen, Norway, and Cleveland, Ohio, collaborated on the predictive model

Research indicates suppressive valacyclovir could help patients avoid keratitis and iritis flare-ups

Valerie Biousse, MD, from the Emory University in Atlanta, Georgia, shared insights on how ocular imaging in the emergency department can provide timely, accurate diagnosis while also benefiting the on-call ophthalmologists.

Joanne F. Shen, MD, director of the dry eye clinic at Mayo Clinic's campus in Phoenix, Arizona, and a research team studied 35 patients treated with IPL/MGX. The team reviewed demographics, ocular histories, Standard Patient Evaluation of Eye Dryness 2 symptom survey scores, slit-lamp examinations and meibomian gland evaluations at baseline and at each visit before IPL/MGX treatments.

Researchers receive $6.4 million grant from NEI to seek new treatment for blindness-causing diseases.

Removing drops from procedure increases adherence and comfort for most patients.

They went on to explain that biomarkers such as VD in the superior capillary plexus (SCP), deep capillary plexus (DCP), and foveal avascular zone (FAZ) are promising because previous studies have reported changes in vascular density in the brain and retina in AD.

Moving on from medication “stacks” and the old-school reactive approach

NEI Initiative aims to boost awareness, standardize diagnosis, and improve care for children with CVI through multidisciplinary collaboration and emerging technologies.

The integration of artificial intelligence in laser cataract technology is shifting the paradigm for the future of cataract surgery and is driving increased precision and improved outcomes for patients.

The authors reported significant variability in DED-related symptoms, with higher prevalence rates among university students and administrative workers.

Corneal confocal microscopy, semaglutide therapy offer treatment options

Jibran Sharieff, MD, and Brandon Kingrey, MD, discuss their innovative smartphone-based device for affordable retinal imaging, highlighting its potential to enhance eye care accessibility and education in low-resource settings.

In an interview with Ophthalmology Times, Ashley Brissette, MD, discusses her skincare brand, Daily Practice, created to address eye health concerns. Motivated by patient requests, she emphasizes the importance of ophthalmologist-tested products that ensure safety around the eyes. Brissette aims to integrate eye care into daily routines for all patients.

The authors reported significant variability in DED-related symptoms, with higher prevalence rates among university students and administrative workers

Julie Schallhorn, MD, MS, also is an associate professor of ophthalmology at the University of California San Francisco, has drawn upon her bioengineering background to develop a device to simplify eye drop administration.

Glenn C. Yiu, MD, PhD, from the University of California David, shared insights from his presentation on suprachoroidal drug delivery in the real world at this year's AAO meeting held in Chicago, Illinois.

74% of participants dosed with LNZ100 achieved 3 or more lines of improvement 3 hours post-treatment.

The Gr8 Eye Movement campaign by Prevent Blindness and Regeneron emphasizes the critical role of caregivers in eye health, revealing significant gaps in caregivers' awareness of retinal diseases and aging-related vision loss.

OCT-based AI analysis brings changes in GA and therapeutic responses into sharp focus.

These residents won second place at the Eyecelerator competition held prior to this month’s American Academy of Ophthalmology conference in Chicago, receiving a $15,000 prize—the first such prize awarded to residents—for their development of a smartphone device designed to take fundus images.

The company reported that Duravyu 2.7mg demonstrated an early and sustained anatomical improvement mirroring BCVA results with a 68 micron reduction in CST. Full topline data is anticipated in Q1 of 2025.

According to the company, Duravyu 2.7 mg demonstrated an early and sustained anatomical improvement mirroring BCVA results with a 68 micron reduction in CST. Full topline data is anticipated in Q1 of 2025.

A study led by researchers at the University of Birmingham finds AI-powered models can match ophthalmologists in diagnosing infectious keratitis, offering promise for global eye care improvements.

Tarver is a board-certified ophthalmologist with a doctorate in epidemiology and has held various leadership positions at the FDA as a medical device regulator, helping drive strategic initiatives, conduct clinical research and changing organizational culture.

Vikas Chopra, MD, led a course on minimally invasive glaucoma surgery (MIGS) and its impact on glaucoma care. He explained that MIGS enables ophthalmologists to intervene earlier and more safely, which can lead to better outcomes for patients.